AlphAIAlphAI — Financial news for AI agents
en.cryptonomist.chOCT 62 min read$OPCH

Option Care stock jumps 32.88% on takeover agreement

Option Care Health (OPCH) shares rose 32.88% to $31.055 after McKesson and Clayton Dubilier & Rice agreed to acquire the company for $32.05 per share, according to Seeking Alpha. The $5.8 billion deal has driven the stock above key technical levels, with the daily RSI14 at 83.76, indicating overbought conditions.

Original reporting
en.cryptonomist.ch
Published Oct 6, 2026, 2:08 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 6, 2026, 3:25 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
Option Care stock jumps 32.88% on takeover agreement — source image
Source · en.cryptonomist.ch
Decision brief

The 30-second read

$OPCHBullishHigh
01

Why it matters

The announcement triggers a sharp price rally, with the stock trading near the offer price and likely to test the $32.05 level.

02

Market read

The deal is material for the healthcare sector and creates a short‑term trading opportunity on OPCH.

03

What to watch

Potential antitrust review and integration risk could delay closing and affect price.

Relevance 9/10Novelty 9/10Timing: pre‑market today

Background

Option Care Health (OPCH) is a provider of home infusion services; the acquisition by McKesson and CD&R values the company at $5.8B including debt.

Company-level read

Ticker impact

$OPCHBullishHigh confidence
Context

Option Care Health announced a definitive acquisition agreement with McKesson and Clayton Dubilier & Rice at $32.05 per share, driving a 32.88% price jump.

Expected impact

likely upward pressure as traders price in the $32.05 offer

Evidence & confidence

A large $5.8B takeover at a premium to the market typically fuels buying until the deal closes.

Market effects

Sector

Consolidation in the home infusion and specialty pharmacy sector may pressure peers.

Regional

U.S. healthcare services market sees increased M&A activity.

Global

Limited to U.S. healthcare and specialty pharmacy investors.

Counterpoint

What could challenge this read

If the deal faces regulatory hurdles, the stock could fall sharply below current levels.

Key entities

  • Company
    Option Care Health

    Target of the acquisition.

  • Company
    McKesson

    Acquirer in the deal.

  • Private Equity
    Clayton Dubilier & Rice

    Co‑acquirer in the deal.

Read at source← All news

StoryCD&R and McKesson agree to acquire Option Care Health

Also covered by

4 outlets

Related articles

OCT 30
$BTSGHighAI 9/10

BrightSpring Soars 12% on Q3 Beat and Raised 2026 Guidance as Adjusted EBITDA Jumps 42%

BrightSpring Health Services (BTSG) stock rose 12% after Q3 earnings beat estimates, with revenue up 26% to $4.21B and adjusted EBITDA up 42% to $228M. The company raised its 2026 guidance. Gross profit per script increased 27%, and home health census grew 58% due to acquisitions from UnitedHealth's Amedisys and LHC Group. Option Care Health (OPCH) and CVS Health (CVS) report next week, which may indicate if BrightSpring's pricing gains are industry-wide.

finance.yahoo.com6 min
OCT 10
$OPCHMed

Key deals this week: Option Care Health, PTC, Energy Transfer and more

Service Properties Trust (SSVC) received a $2.0B acquisition offer from TKO LLC. Viatris (VTRS) agreed to buy Pacira BioSciences (PCRX) for $1.65B. Option Care Health (OPCH) surged 34% after a $5.8B acquisition deal with CD&R and McKesson (MCK). Energy Transfer (ET) will acquire Vaquero Midstream for $2.625B. Emera (EMA) and Canadian Utilities (CDUAF) agreed to a $10B merger. Cenovus Energy (CVE) will acquire Athabasca Oil (ATHOF) for ~$5.7B.

tradingview.com1 min
OCT 10
$OPCHHighAI 9/10

Option Care Health Sold for $5.8B in CD&R-McKesson Deal

Option Care Health (OPCH) is being acquired by CD&R and McKesson (MCK) for $5.8B, or $32.05 per share, a 37% premium. The deal, expected to close in 2027, values the company at $5.8B. Option Care Health will operate independently post-acquisition. The company reported $5.6B in 2025 revenue and $207.6M in net income, with modest growth in 2026. The acquisition aligns with McKesson's strategy to expand access to innovative therapies.

hoodline.com2 min
OCT 9
$MCKHighAI 9/10

McKesson (MCK) Joins $5.8 Billion Option Care Health (OPCH) Acquisition. Is the Valuation Justified?

McKesson (MCK) is acquiring Option Care Health (OPCH) for $5.8B, including debt, at $32.05 per share, a 37% premium. McKesson and private equity firm CD&R will own 49% and 51% respectively. The deal expands McKesson's specialty healthcare services. McKesson's Q1 2027 revenue was $105.4B, beating estimates, with adjusted EPS up 20% YoY to $9.93. The company raised its fiscal 2027 adjusted EPS guidance to $44.20-$45.00.

finance.yahoo.com2 min
OCT 7
$OPCHHighAI 9/10

Infusion therapy provider being acquired in $5.8 billion deal

Option Care Health (OPCH) is being acquired by CD&R and McKesson in a $5.8 billion deal, expected to close in early 2027. CD&R will hold majority ownership, with McKesson holding a minority stake. Option Care Health shares were trading at $31.02, up from $23.34 before the acquisition news. The company will remain separate but will delist from Nasdaq post-deal.

wfmz.com2 min